Pleural Drainage
Physiology, Mechanism and Interpretation

1. Pleural physiology — what the space does

Normal pleural fluid

Normal human pleural fluid volume, measured by pleural lavage in healthy participants undergoing thoracoscopic sympathectomy for hyperhidrosis, is approximately 0.16 to 0.36 mL/kg of body weight — less than 12 mL per hemithorax in most adults [1]. The fluid is distributed as a film of 10 to 20 µm thickness, thickest in the dependent regions. It originates predominantly from the parietal pleural microvasculature, which sits 10 to 12 µm from the pleural space and operates under systemic arterial pressure with relatively high microvascular permeability. The fluid is a low-protein filtrate (pleural-to-serum protein ratio approximately 0.15) consistent with systemic interstitial filtrates elsewhere in the body, and is cleared via parietal pleural lymphatic stomata of 6 to 10 µm diameter that drain into a rich lymphatic network connecting to the central veins. Entry and exit rates in awake sheep are approximately 0.01 mL/(kg·h), corresponding to roughly 15 mL/day in a 60-kg human at steady state.

Three features of normal pleural physiology bear directly on drainage. First, the lymphatic reserve is substantial — up to thirty times the baseline exit rate when challenged with experimental volume loading [1]. This is why most modest increases in fluid production do not produce a clinically detectable effusion: the lymphatics absorb the additional load. An effusion develops when entry rate exceeds maximal lymphatic exit, when the lymphatic system is itself impaired, or both. Second, the protein concentration of pleural fluid does not change as a hydrothorax is absorbed, because exit is by bulk flow through the stomata rather than by selective diffusion — which is the physiological justification for the Light criteria distinction between transudates (pleural-to-serum protein ratio <0.5) and exudates (>0.5). Third, the space is subatmospheric throughout the breathing cycle — the consequence of the inward elastic recoil of the lung and the outward recoil of the chest wall acting in opposite directions across the pleural surface.

Intrapleural pressure — the mechanical anchor

West’s analysis of intrapleural pressure, derived from physiological measurement in animals and corroborated by micropipette work in humans, anchors the surgical understanding [2]. At functional residual capacity, intrapleural pressure averages approximately −5 cmH₂O, with a vertical gradient from approximately −8 cmH₂O at the apex to −2 cmH₂O at the base. During quiet inspiration the pressure becomes more negative, falling to approximately −8 cmH₂O; during forced expiration in normal lungs it rises slightly but remains subatmospheric. In severe airflow obstruction with dynamic hyperinflation, intrapleural pressure may become more positive at end-expiration than at end-inspiration — the physiological signature of intrinsic PEEP.

The clinical consequence is that the lung is held expanded by the negative pressure difference between the intrapleural space and the alveolus — the transpulmonary pressure. If this pressure difference is lost — by air entering the space (pneumothorax) or by fluid filling the space (effusion compressing the lung) — the lung collapses inward to its natural unstressed volume, which is approximately 30 to 35 per cent of total lung capacity. Drainage works by re-establishing the pressure differential. The lung expands not because the drain pulls it back into shape, but because the elastic recoil that was previously balanced against atmospheric pressure can now act against subatmospheric pressure again.

Figure 1

Effusion formation — the three pathways

A pathological pleural effusion forms when entry exceeds exit. Three mechanisms operate, often in combination [1]:

Increased entry rate: most commonly through increased microvascular permeability (malignancy, infection, vasculitis), increased microvascular pressure (heart failure), or increased filtration surface area. Entry rates above approximately 0.28 mL/(kg·h) — roughly 400 mL/day in a 60-kg human — will overwhelm even maximal lymphatic clearance.

Decreased exit rate: lymphatic obstruction by tumour infiltration, scarring after radiation or surgery, fibrinous occlusion of stomata in parapneumonic effusion, or downstream venous hypertension. An isolated 50 per cent reduction in lymphatic capacity is generally clinically silent until entry rises; a near-total occlusion can produce effusion without any entry-rate increase, though this is uncommon.

Both mechanisms together: the most clinically common pattern. Heart failure produces both increased entry (raised pulmonary capillary pressure) and decreased exit (raised central venous pressure impeding lymphatic drainage). Malignancy similarly combines elevated VEGF-driven permeability with lymphatic infiltration. Parapneumonic effusion combines inflammatory exudation with fibrinous stomatal occlusion. The dual mechanism is the reason effusions can reach a litre or more before clinical detection — the system has substantial reserve, and clinical presentation marks the point at which the reserve has been overwhelmed in both directions.

Light criteria — the protein-ratio inference

The Light criteria, derived by Richard Light and colleagues in 1972 and refined since, classify an effusion as transudative or exudative on the basis of protein and lactate dehydrogenase ratios between pleural fluid and serum. The classification matters because it directs the differential diagnosis: transudates point to systemic problems (heart failure, hepatic hydrothorax, hypoalbuminaemia, nephrotic syndrome) while exudates point to pleural or pulmonary disease (malignancy, infection, pulmonary embolism, autoimmune disease). The mechanism behind the criteria is straightforward: the bulk-flow exit pattern of normal pleural fluid means protein concentration does not change appreciably during absorption, so a high pleural-to-serum protein ratio signals a vascular bed with abnormally high permeability — an exudate. The detail is covered in the patient-facing PleurX page at clinical depth; the physiological grounding is here.

2. Why drainage works — the mechanism of evacuation

A chest drain accomplishes three mechanical tasks simultaneously. It evacuates air or fluid from the pleural space, restoring volume. It prevents re-entry of air through the drain itself, by means of a one-way valve mechanism (water seal or its modern equivalents). And it allows controlled negative pressure to be applied, by suction, to accelerate evacuation and oppose any continued source of air or fluid entry. Every drainage system since Playfair’s original three-bottle apparatus has been a refinement of these three functions.

The water seal — the original one-way valve

The water seal is the conceptual heart of every chest drainage system. A column of water of known height (typically 2 cm) sits between the patient-side limb of the drain and atmosphere. During expiration, intrapleural pressure rises and air bubbles out through the water; during inspiration, intrapleural pressure falls and the water column rises (oscillation or “swing”), but cannot be drawn fully into the patient because the column height resists upward flow at any negative pressure less than the column height. The water seal is therefore a passive one-way valve calibrated to atmospheric pressure plus the column height — a remarkably elegant physical solution to a clinically important problem.

Two clinical inferences follow. Bubbling at rest indicates active air movement out of the pleural space — the signature of an air leak. Swing without bubbling indicates a patent drain communicating with the pleural space but no active leak — the lung is expanding and contracting normally, the column moving in response to the patient’s breathing. No swing and no bubbling indicates either a fully sealed pleural space with the drain in its correct position (the goal of drainage), or a blocked drain (a problem to be excluded). The clinical observation set has not changed in 150 years. What has changed is the modality of observation: from continuous bedside attention to bubble character, to once-daily ward-round inspection, to continuous electronic monitoring of mL/min air flow with trend logging.

Suction — controlled negative pressure

Suction adds active evacuation to the passive water seal. The level of suction matters. Typical surgical practice is −20 cmH₂O continuous suction in the immediate postoperative period, sometimes −10 to −15 cmH₂O in patients with significant emphysema or marginal lung reserve where higher negative pressures risk drawing alveolar gas into the pleural space (paradoxically increasing the apparent leak) or causing pain from over-evacuation. Suction is reduced or withdrawn in the days following surgery as the leak resolves and the lung re-expands. The shift from suction to water seal alone is itself a clinical decision — one taken too cautiously prolongs hospital stay; one taken too aggressively risks pneumothorax recurrence and surgical emphysema.

Digital systems offer stable electronic suction — the negative pressure is held constant regardless of patient position, ambulation, or apparatus disturbance. This is meaningful because the older underwater seal systems depend on the patient’s position relative to the bottle and on the bottle’s height below the chest. A patient standing up from a chair with an underwater seal experiences a transient change in the effective suction level. With a digital system the suction is electronically regulated and unaffected.

3. The historical arc — three-bottle to digital

Pleural drainage has evolved through four discrete generations, each refining the same underlying physics. The architecture has progressed from inelegant but functional glass bottles, through integrated moulded units, to electronic systems with continuous data logging. The mechanical principles have not changed.

Figure 2

The trajectory is one of steadily increasing information density with steadily decreasing labour requirement. A three-bottle system required continuous bedside attention to manage; a digital system displays a trend line that anyone walking past the bedside can read at a glance. The clinical decisions have not become more complex; the data available to make them has become more granular and more continuous.

The transition that has not happened — ambulatory Thopaz

A distinction worth making explicit. Thopaz is a portable, battery-operated digital drainage system. Its portability has been used by some centres to support ambulatory pleural drainage outside hospital. This is not how Thopaz is used at GSTT or in our private practice at London Bridge Hospital. The system requires periodic charging, must be kept upright, and demands medical supervision when air leak is significant. Sending a patient home with a Thopaz expecting them to manage these requirements without inpatient support is, in our judgement, inappropriate — particularly when the patients who would otherwise need a drain home are typically those with persistent air leak from severe parenchymal disease, a population not well served by self-managed discharge.

Where home drainage is used — an uncommon situation in our practice — it is for the rare patient with prolonged air leak who, after appropriate discussion, accepts a flutter bag or Heimlich-type one-way valve and continued outpatient follow-up. We always offer the alternative of remaining in hospital until the leak resolves, and most patients prefer that. Home discharge with a Thopaz is, in our hands, not done. The relevant ambulatory pathway in our practice is the indwelling pleural catheter, covered in section 8.

4. What digital drainage actually measures

Air flow quantification

The system measures air flow at the drain’s expiratory limb using a calibrated flow sensor. The reading is updated continuously and displayed as a digital figure on the unit, typically with a graphical trend line of the preceding 6 to 24 hours. Air flow is reported in mL/min and ranges from zero (no leak) through the Cerfolio bands (minimal <100, moderate 100–400, large >400) to figures in the thousands of mL/min in the immediate postoperative period after substantial alveolar injury or after some major lung resections [3]. The continuous measurement is the central advance over the underwater seal era. A 200 mL/min steady leak that would have been read as “moderate bubbling on coughing” on a ward round is now quantified to the minute.

Fluid output and stable suction

Fluid is collected in a disposable canister with electronic level sensing and the volume is logged digitally. The advantage over a graduated underwater seal collection chamber is mainly accuracy at low volumes and the ability to integrate the measurement into the same continuous record as air flow.

Suction is applied by the unit’s electronic regulator and held at a set value (typically −10 to −20 cmH₂O for surgical drainage). Critically, the actual applied pressure is measured at the patient end of the drain, not just at the unit, so the patient experiences the prescribed pressure rather than the prescribed-minus-friction-loss pressure that an underwater seal with separate wall suction will deliver. Position changes do not alter the suction. Ambulation does not alter the suction. The clinical implication is that bedside-to-armchair-to-bathroom movement does not break the negative pressure cycle, and that the trend line genuinely reflects the patient’s physiology rather than the patient’s movements over the preceding 24 hours.

The Brunelli evidence base

Alessandro Brunelli and colleagues at Ancona published the first randomised trial of digital versus traditional underwater seal drainage after lobectomy in 2010 [4]. The primary endpoint was chest drain duration. Digital drainage reduced drain time by approximately 0.9 days and length of hospital stay by approximately 0.7 days. Subsequent ESTS publications, including a multicentre European randomised trial, have replicated the finding across different patient populations and surgical settings. The mechanism is straightforward: when continuous quantitative data are available, clinicians remove the drain earlier and more confidently than when they rely on once-daily bubble inspection. The technology does not make the decision; it makes the decision more readily available, more accurate, and more reproducible across teams and shifts.

Brunelli has subsequently led ESTS work on digital drainage standardisation, drain removal criteria, and post-resection air leak management [5]. The body of work converges on a single conclusion: continuous quantification of air leak should be the default in modern thoracic surgical practice. Underwater seal drainage remains correct — it is mechanically the same physics — but the data density is substantially lower, and the clinical decisions made on it are correspondingly less precise.

5. Air leak interpretation — the Cerfolio classification

Volume thresholds

A minimal air leak (under 100 mL/min) is consistent with alveolar leak at the staple line or from small parenchymal injuries. Most will close spontaneously within 48 to 72 hours. Drain removal can typically proceed when the leak falls below 20 to 30 mL/min sustained for several hours, or zero on a brief test of water seal without suction.

A moderate air leak (100 to 400 mL/min) suggests larger alveolar communication or a small peripheral airway injury. Many will settle with conservative management over 5 to 7 days; persistence beyond that defines a clinical entity requiring escalation. The Cerfolio paper itself defined persistent air leak as one lasting beyond postoperative day five [3], with subsequent literature variously using 5, 7, or 14 days as the threshold. Operationally we use 5 days as the trigger for active escalation planning, with intervention itself typically considered around day 7.

A large air leak (over 400 mL/min) signals significant alveolar-pleural or bronchopleural communication. Some are early postoperative findings that settle rapidly as parenchymal injuries seal; others persist and require escalation. A large air leak that is not clearly improving over 24 to 48 hours, particularly when accompanied by surgical emphysema or by impaired re-expansion of the lung on chest radiograph, warrants early planning of next steps rather than continued passive observation.

Waveform pattern

The shape of the air leak curve adds clinical information beyond the headline number. Three patterns are clinically useful:

Continuous leak: air flow throughout the breathing cycle, present at rest. Typical of a substantial alveolar-pleural fistula or a bronchopleural fistula. Generally requires more active management.

Forced expiratory leak: air flow only on cough or forced expiratory effort. Typical of a smaller alveolar leak that closes at end-expiration and reopens transiently with intrathoracic pressure peaks. Generally settles with conservative management and time.

Inspiratory leak: air flow on inspiration but not at rest or on expiration. Rare; typically indicates a check-valve mechanism through a small bronchopleural defect that opens on negative intrathoracic pressure and closes on positive. Generally requires bronchoscopic assessment.

Figure 3

Digital systems do not replace waveform pattern recognition; they enhance it. The continuous curve makes the pattern visible to anyone walking past the bedside, where the underwater seal era required a deliberate examination at the right moment in the patient’s breathing cycle.

Trajectory — the decision-defining variable

A single Cerfolio reading does not decide management. The trajectory across 24 to 48 hours does. A 200 mL/min moderate leak on day one of a known intraoperative alveolar injury, falling to 50 mL/min by 24 hours and to zero by 48 hours, is a physiologic settling leak. The same 200 mL/min reading sustained or rising across 48 hours, with a continuous (not just forced-expiratory) waveform pattern, is a clinically different problem requiring planning of escalation. The Brunelli digital drainage work formalised trajectory as the decisive variable rather than any single reading, and modern practice is built on that formalisation.

The integrated picture — volume, waveform pattern, trajectory, and underlying parenchymal substrate — defines what comes next. In a previously well patient with a small post-lobectomy alveolar leak, observation for 5 to 7 days is appropriate. In a patient with severe bullous emphysema and a large continuous leak with no downward trajectory on day three, planning for escalation begins at day three, not day seven, because the probability of spontaneous resolution falls steeply when the parenchymal substrate is itself diseased.

6. The clinical discriminations that matter

Four discriminations are made on the data that a chest drain provides. Each one separates clinical pathways that are entirely different despite sharing the same drainage hardware.

Air leak versus trapped lung

Two clinical problems on the same drain readout, with entirely separate escalation pathways. An air leak is a fistulous communication between the airway or alveoli and the pleural space. The Thopaz registers continuous or cough-provoked air flow; the lung partially expands but persists in losing air; the underlying surgical question is whether and how to close the fistula. Trapped lung is a parenchymal stiffness problem. The visceral pleura is thickened or scarred (by previous infection, chronic inflammation, or tumour infiltration); the lung does not fully re-expand once any pleural fluid is drained; fluid re-accumulates in the space the lung does not fill; the Thopaz typically registers fluid output without significant air flow once any initial drainage equilibrium is reached. Air leak escalates through conservative observation, blood patch, talc pleurodesis, surgical revision, or EBV. Trapped lung escalates through indwelling pleural catheter for symptom control, or decortication where physiologically appropriate. The discrimination is made on the integrated picture, not on a single drain reading.

Settling versus persistent

A reading at one time point does not discriminate. A trajectory does. Two patients can have an identical 150 mL/min air leak at 09:00 and identical chest radiographs and identical underlying disease — and have entirely different prognoses depending on whether the 09:00 reading is the same as yesterday’s reading, lower, or higher. The Brunelli digital drainage publications formalised trajectory-based decision-making in postoperative care. The principle generalises: where digital data is available, decisions should be made on the trend, not on the snapshot.

Surgical versus bronchoscopic candidacy

Where escalation is needed, the choice between surgical revision and bronchoscopic intervention depends on patient factors, the location and size of the leak, and the local availability of expertise. Surgical revision — VATS or open re-exploration with direct closure or further resection of the leaking parenchyma — is the appropriate choice in the fit patient with a focally identifiable leak amenable to direct closure. Bronchoscopic EBV is the appropriate choice in the patient who cannot tolerate further surgery, in whom the parenchymal substrate is too diseased to support reliable surgical closure, or in whom critical illness on extracorporeal life support makes operative re-entry infeasible. The two options are complementary, not competing; the patient phenotype decides.

In-hospital versus home drainage

Most pleural drainage is delivered as an inpatient, with the drain removed before discharge. Two situations require continued drainage after discharge. First, the rare patient with prolonged air leak after lung resection, who is offered a flutter bag or Heimlich-type one-way valve as an alternative to continued inpatient stay (and in our practice is generally offered the alternative of remaining in hospital, which most accept). Second, the patient with trapped lung and recurrent pleural fluid, for whom an indwelling pleural catheter is the appropriate ambulatory option. Thopaz is not used for home drainage in our practice — the device requires medical supervision and is unsuited to unsupported community management. The patient pathways are entirely separate; the patient-facing companion page (PleurX for trapped lung) sets out the IPC pathway in plain English.

7. Persistent air leak — the escalation pathway

Step 1 · Conservative observation under suction

The first step is unglamorous and effective. Continuous suction at −10 to −20 cmH₂O for 5 to 7 days, with optimised pain control to permit deep breathing and effective cough, allows the majority of postoperative air leaks to resolve through alveolar healing. Hand-held incentive spirometry, early ambulation, and pulmonary physiotherapy assist re-expansion of the lung against the chest wall, which itself promotes leak closure. The threshold for moving to the next step varies by surgical and patient factors, but typically active escalation planning begins at day 5 if the trajectory shows no decline, and intervention is considered at day 7.

Step 2 · Autologous blood patch

A pleural autologous blood patch involves drawing 50 to 100 mL of the patient’s own venous blood and instilling it through the chest drain into the pleural space, the drain then clamped briefly to retain the blood in contact with the visceral pleura. The mechanism is presumed to be a combination of clot adherence to the leaking surface and induction of localised inflammation that promotes fibrinous sealing. The technique was first described in the 1980s and has a small but consistent series-level evidence base; the published response rate in selected patients is in the 50 to 70 per cent range, with the caveat that publication bias inflates the apparent success rate. Adverse events include localised infection (uncommon) and tension physiology if the drain is clamped beyond its safe period (avoided by careful protocol). Blood patch is appropriate as a low-cost low-risk attempt before talc or before surgical revision; it is not a substitute for definitive intervention if the leak persists.

Step 3 · Talc pleurodesis

Talc pleurodesis — the controlled inflammation that adheres the visceral and parietal pleura through fibrous obliteration of the pleural space — is the canonical intervention for recurrent malignant pleural effusion and a reasonable adjunct in selected persistent air leak cases. The mechanism requires the two pleural surfaces to be in apposition; in malignant pleural effusion this is reliably achieved once the fluid is drained and the lung re-expands. In persistent air leak the situation is different: the underlying fistula prevents stable lung expansion against the chest wall, so the surfaces are not in reliable contact, and the pleurodesis is correspondingly less reliable. Talc is useful in selected air leak patients — particularly when the leak is small and the lung is otherwise expanding well — but the clinical impression is that it is less effective in this setting than in malignant effusion, and escalation to surgical revision or EBV is more often required when the fistula is significant.

Step 4 · Surgical revision

Where the patient is fit for further surgery and the leak is focally identifiable on bronchoscopy or on intraoperative inspection, VATS re-exploration with direct closure or limited further resection is the appropriate option. The published success rate is high in selected patients, and the procedure is well tolerated when undertaken at the appropriate point in the escalation rather than as a salvage attempt months later. Open re-thoracotomy is reserved for cases where VATS access is not feasible because of pleural adhesions or anatomical reasons. Surgical revision is the right answer in the fit patient with a discrete identifiable leak; it is not the right answer in the patient who cannot tolerate further anaesthesia or in whom the parenchymal substrate is too diseased to support reliable closure.

Step 5 · Bedside bronchoscopic endobronchial valve placement

Endobronchial valves applied to persistent air leak are the same device used for emphysema lung volume reduction, applied to a different clinical problem. The valves are placed bronchoscopically in the airway segment supplying the bronchopleural fistula; once that segment is occluded, the air leak typically resolves immediately, allowing chest drain removal. The technique can be performed at the bedside under sedation and topical anaesthesia in patients in whom transport to the bronchoscopy suite is unfeasible, including patients on invasive mechanical ventilation and patients on extracorporeal life support [8].

The three canonical clinical situations are unchanged from those described in the emphysema flagship reference [Emphysema Surgery in 2026]. First, persistent post-surgical air leak after pulmonary resection where conservative management has failed and the patient is unsuitable for or has declined surgical revision. Second, persistent air leak complicating secondary spontaneous pneumothorax on a background of bullous emphysema or COPD, where the underlying disease overlaps substantially with the lung volume reduction population. Third, critically ill patients with severe parenchymal disease in whom surgery would carry unacceptable risk, with the COVID-19 ARDS on VV-ECMO cohort as the defining recent example.

The patient population for EBV in persistent air leak overlaps substantially with the lung volume reduction population. Many of these patients have underlying bullous emphysema or significant COPD, and many of them — once the acute leak is resolved — benefit from formal lung volume reduction assessment in the same MDT pathway. Same device, two indications, overlapping patient population, different points in the disease trajectory. The unification is the substantive clinical insight: a patient who presents with secondary spontaneous pneumothorax on a background of severe emphysema, who is treated acutely with EBV for the air leak, may subsequently re-present for formal LVR assessment for the underlying disease that produced both the bullous architecture and the persistent leak.

Step selection — not protocol order

The escalation steps are not a fixed sequence to be followed in order regardless of clinical context. Steps are selected on patient phenotype and feasibility. A patient with severe emphysema, a large continuous postoperative air leak from day one, and obvious bullous architecture on CT may move from conservative observation directly to EBV planning, bypassing blood patch and talc that have low expected probability of success in that substrate. A previously well patient with a small forced-expiratory leak after lobectomy will appropriately stay at conservative observation for the full 5 to 7 days before any escalation. The framework is structured; the application is patient-specific.

8. Ambulatory drainage in surgical practice

Most pleural drainage in our practice is delivered as an inpatient and the drain is removed before discharge. Three ambulatory situations are worth setting out explicitly because they are the situations most often confused in referral conversations.

Thopaz is not used for home drainage

Thopaz requires charging, must be kept upright, and demands medical supervision when air leak is significant. The portability of the device has been used by some centres to support short-term ambulation within the hospital and, in some published protocols, to support home discharge. This is not how Thopaz is used at GSTT or in our private practice at London Bridge Hospital. The patients who would otherwise be candidates for Thopaz home discharge are typically those with persistent air leak from severe parenchymal disease — a population not well served by self-managed home drainage of a device requiring upright orientation and periodic charging.

Flutter bag and Heimlich-type one-way valves for home discharge

Where home drainage with a chest drain is genuinely necessary, the appropriate device is a flutter bag or small Heimlich-type one-way valve. The system contains a one-way silicone duckbill valve that allows air or fluid to leave the pleural space on positive intrathoracic pressure and prevents return on negative pressure. It does not require electronic regulation, does not need charging, and is robust to position changes. Home discharge with a flutter bag is appropriate for the rare patient with prolonged air leak who, after detailed discussion, prefers to continue drainage at home rather than as an inpatient. In our practice we always offer the alternative of remaining in hospital until the leak stops, and the majority of patients choose that. Home discharge with a chest drain is the exception, not the routine.

Indwelling pleural catheter — a separate pathway

The indwelling pleural catheter (IPC) is a different clinical entity from a postoperative chest drain. It is a small soft silicone catheter tunnelled under the skin and used for long-term intermittent drainage of recurrent pleural fluid, most commonly malignant pleural effusion with trapped lung. The technique is established (Lee, Light NEJM 2018 [9]; Thomas et al, AMPLE trial JAMA 2017 [10]) and the indication is symptom control rather than cure: the lung is trapped, talc pleurodesis cannot work because the two pleural surfaces cannot be brought into contact, and the IPC manages the fluid as it forms. The drainage is intermittent — typically twice weekly by district nurses, sometimes by the patient or family — using single-use vacuum bottles. The smaller benign cohort comprises chronically trapped lung in frail patients in whom decortication is inappropriate or carries excessive risk. The patient-facing companion page on IPCs →

The three ambulatory pathways are entirely separate. Thopaz is in-hospital, period. Flutter bag is an exception for rare prolonged air leak. Indwelling pleural catheter is the established long-term ambulatory device for trapped-lung fluid management. Conflating them in clinical conversation produces confusion; separating them in clinical practice produces appropriate care.

Summary

Pleural drainage is the oldest continuous practice in thoracic surgery and the one whose physiology has changed least. The lung is held expanded by the negative intrapleural pressure difference between the pleural space and the alveolus. Drainage works by restoring that pressure differential. Every drainage system from Playfair’s three bottles to Medela’s digital Thopaz has been a refinement of three mechanical tasks: evacuation, one-way valving, and controlled suction.

What has changed in the last decade is the data density and decision precision available at the bedside. Continuous mL/min air flow quantification, stable electronic suction, and 24–48 hour trend logging have replaced once-daily bubble inspection. Cerfolio’s volume thresholds and Brunelli’s ESTS digital drainage publications formalised what surgeons previously called by feel. The decision to remove the drain, to escalate suction, to attempt blood patch, to proceed to talc pleurodesis, to return to theatre, or to place endobronchial valves is now made on integrated trajectory data rather than on single-time-point inspection.

The persistent air leak escalation pathway is the area where the integration of physiology, modern interpretation, and the EBV technique converges. Conservative observation, blood patch, talc, surgical revision, and bedside bronchoscopic EBV are not a fixed sequence but a structured set of options selected on patient phenotype and feasibility. EBV defines the upper limit of what is possible — including in patients on extracorporeal life support whose previous prognosis was uniformly poor — and the GSTT VV-ECMO series, on which Mr Okiror is joint senior author, established the bedside technique in the published literature.

The underlying principle is unchanged. Restore the negative pressure; the lung re-expands. Lose it; the lung collapses. Everything that follows is a refinement of that single physics.

References

1. Broaddus VC. Fluid and solute exchange in normal and disease states. In: Light RW, Lee YCG, editors. Light’s Pleural Diseases, 7th edition. Wolters Kluwer; 2021: chapter 5, pp 49–57. (Canonical source for pleural fluid physiology: normal pleural fluid volume 0.16–0.36 mL/kg; lymphatic clearance up to 30× baseline; effusion mechanisms; Light criteria origin.)
2. West JB, Luks AM. West’s Respiratory Physiology — The Essentials, 11th edition. Wolters Kluwer; 2021: chapter 7, “Mechanics of Breathing”. (Intrapleural pressure mechanics: subatmospheric pleural pressure, transpulmonary pressure gradient, lung recoil, dynamic compression of airways.)
3. Cerfolio RJ, Bryant AS. The management of chest tubes in patients with a pneumothorax and an air leak after pulmonary resection. Chest 2008;133(5):1099–1101. (Cerfolio classification of postoperative air leak: minimal, moderate, large air leak with mL/min thresholds; definition of persistent air leak by duration.)
4. Brunelli A, Salati M, Refai M, Di Nunzio L, Xiume F, Sabbatini A. Evaluation of a new chest tube removal protocol using digital air leak monitoring after lobectomy: a prospective randomised trial. Eur J Cardiothorac Surg 2010;37(1):56–60. doi:10.1016/j.ejcts.2009.05.006. PMID 19589691. (First RCT of digital versus traditional underwater seal drainage after lobectomy. Reduced drain time by ~0.9 days and length of stay by ~0.7 days.)
5. Brunelli A, Beretta E, Cassivi SD, et al. Consensus definitions to promote an evidence-based approach to management of the pleural space. A collaborative proposal by ESTS, AATS, STS, and GTSC. Eur J Cardiothorac Surg 2011;40(2):291–297. (ESTS/AATS/STS/GTSC consensus on pleural space definitions and drainage practice.)
6. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection (MIST-2). N Engl J Med 2011;365(6):518–526. (Foundational trial of intrapleural fibrinolytic therapy for pleural infection.)
7. Bedawi EO, Stavroulias D, Hedley E, Hassan M, Asciak R, Mercer R, Najib A, Sundaralingam A, Hallifax RJ, Wrightson JM, Tsikrika S, Kanellakis NI, Maskell NA, Rahman NM. Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection: An Open-Label Study (MIST-3). Am J Respir Crit Care Med 2023;208(12):1305–1314. doi:10.1164/rccm.202305-0876OC. PMID 37820359. (MIST-3 open-label evaluation of tPA/DNase in pleural infection; UK multicentre study.)
8. Ficial B, Whebell S, Taylor D, Fernández-Garda R, Okiror L, Meadows CIS. Bronchoscopic endobronchial valve therapy for persistent air leaks in COVID-19 patients requiring veno-venous extracorporeal membrane oxygenation. J Clin Med 2023;12(4):1348. doi:10.3390/jcm12041348. PMID 36835885. (Mr Okiror joint senior author. GSTT case series: 10 patients on VV-ECMO with refractory air leak; 10/10 air leak resolution with bedside bronchoscopic EBV; 8/10 (80%) survival to hospital discharge. PRO-SEAL trial referenced: ISRCTN15099654, Mr Okiror Co-Principal Investigator at GSTT site, sole EBV operator for the trial.)
9. Lee YCG, Light RW. Indwelling Pleural Catheters for Non-Malignant Pleural Effusions. N Engl J Med 2018;378(23):2189–2191. (Indwelling pleural catheter indications including non-malignant trapped lung.)
10. Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, Horwood FC, Piccolo F, Lam DCL, Garske LA, Shrestha R, Kosky C, Read CA, Murray K, Lee YCG. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial. JAMA 2017;318(19):1903–1912. doi:10.1001/jama.2017.17426. PMID 29164255.
11. Asciak R, Bedawi EO, Bhatnagar R, Clive AO, Hassan M, Lloyd H, Reddy R, Roberts H, Rahman NM. British Thoracic Society Clinical Statement on Pleural Procedures. Thorax 2023;78(Suppl 3):s43–s68. (BTS 2023 statement on pleural procedures: ultrasound guidance, safe triangle, small-bore versus large-bore, training.)
12. Okiror L, Lang-Lazdunski L. Surgery for Pleural Diseases. In: Light RW, Lee YCG, editors. Light’s Pleural Diseases, 3rd edition. CRC Press; 2016: chapter 47. ISBN 978-1-4822-2250-0. (Surgery chapter co-authored by Mr Okiror.)

Frequently asked questions